SCHEMBL6348609

SCHEMBL6348609

N#Cc1ccc(NC(=O)c2nc3ccccc3o2)c(C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
ALB P02768 2/20 0.44
FAAH O00519 1/20 0.44
LMNA P02545 2/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 3/20 0.41
MAPT P10636 4/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPK1 P28482 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
THRB P10828 1/20 0.40
KDM4E B2RXH2 2/20 0.40
PRSS12 P56730 1/20 0.40
CDK2 P24941 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6351958 0.86 MAOB (0.41) KMT2AMEN1RAB9AFAAHLMNA
SCHEMBL6924687 0.80 GALK1 (0.57) KMT2AMEN1NPC1RAB9APKM
SCHEMBL6833642 0.77 RAB9A (0.67) KMT2AMEN1NPC1RAB9AHPGD
SCHEMBL6834034 0.77 TUBB4A (0.55) ALBFAAHHTTHDAC6
SCHEMBL6353963 0.77 KMT2A (0.62) KMT2AMEN1ALBHTTMAPT
SCHEMBL12829834 0.76 THRB (0.43) KMT2AMEN1NPC1RAB9AFAAH
SCHEMBL12830464 0.76 HPGD (0.38) KMT2AMEN1NPC1RAB9AFAAH
SCHEMBL6833895 0.76 SMN1; SMN2 (0.55) KMT2AMEN1NPC1RAB9AALB
SCHEMBL6818221 0.76 ALB (0.44) KMT2AMEN1ALBHTTMAPT
SCHEMBL6830490 0.76 HIF1A (0.55) ALBCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 KMT2A 3645/4885MEN1 3274/4885NPC1 3512/4885
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 KMT2A 2853/4885MEN1 4132/4885NPC1 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.